NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

TEM

Tempus AI Inc

Jul 03 • 04:00PM ET

60.97

Dollar change +1.79
Percentage change 3.02	%

Healthcare • Health Information Services • USA • NASD

Peers: ILMN EXAS GH TXG CRSP PACB NTLA EDIT CDNA TWST

| Held by: ARKK VTI VB ARKG VBK IBB IWP ULTY JTEK BAI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.60	Insider Own	48.04%	Shs Outstand	167.99M	Perf Week	-10.78%
Market Cap	10.55B	Forward P/E	-	EPS next Y	-0.01	Insider Trans	-9.18%	Shs Float	89.94M	Perf Month	-1.60%
Enterprise Value	11.19B	PEG	-	EPS next Q	-0.23	Inst Own	33.01%	Short Float	21.81%	Perf Quarter	22.21%
Income	-721.31M	P/S	13.14	EPS this Y	55.27%	Inst Trans	0.50%	Short Ratio	1.49	Perf Half Y	80.01%
Sales	803.32M	P/B	32.34	EPS next Y	97.88%	ROA	-70.47%	Short Interest	19.61M	Perf YTD	80.60%
Book/sh	1.89	P/C	48.24	EPS next 5Y	-	ROE	-	52W High	91.45 -33.33%	Perf Year	82.87%
Cash/sh	1.26	P/FCF	-	EPS past 3/5Y	-37.97% -32.48%	ROIC	-61.41%	52W Low	30.77 98.15%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	39.06% 38.58%	Gross Margin	55.42%	Volatility	5.33% 6.81%	Perf 5Y	-
Dividend TTM	-	EV/Sales	13.93	EPS Y/Y TTM	-160.27%	Oper. Margin	-87.17%	ATR (14)	4.53	Perf 10Y	-
Dividend Ex-Date	Jul 18, 2006	Quick Ratio	1.56	Sales Y/Y TTM	42.93%	Profit Margin	-89.79%	RSI (14)	45.23	Recom	2.08
Dividend Gr. 3/5Y	- -	Current Ratio	1.71	EPS Q/Q	27.16%	SMA20	-8.13%	Beta	5.23	Target Price	66.70
Payout	-	Debt/Eq	2.63	Sales Q/Q	75.38%	SMA50	-1.37%	Rel Volume	0.49	Prev Close	59.18
Employees	2400	LT Debt/Eq	2.60	Earnings	May 06 AMC	SMA200	13.79%	Avg Volume	13.16M	Price	60.97
IPO	Jun 14, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.69% 3.07%	Trades		Volume	6,387,854	Change	3.02%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-21-25	Initiated	BTIG Research	Buy	$60
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44
Jul-09-24	Initiated	Loop Capital	Buy	$48
Jul-09-24	Initiated	Longbow	Buy	$48
Jul-09-24	Initiated	JP Morgan	Overweight	$42
Jul-09-24	Initiated	BofA Securities	Buy	$41

Show Previous Ratings

Jul-05-25 12:22PM	Why Tempus AI Stock Soared 15.2% in June (Motley Fool)
Jul-04-25 08:43AM	Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release (Zacks)
Jul-03-25 12:01PM	Hims & Hers Enhances Healthcare Through AI-Driven Personalization (Zacks)
Jul-02-25 10:28AM	Tempus AI (TEM) Falters on $400-Million Debt Issue (Insider Monkey)
08:11AM	What's Fueling Tempus AI's Explosive Sales Growth? (Zacks)
10:43PM	Loading…
Jun-30-25 10:43PM	Tempus Announces Pricing of Upsized Offering of $650 Million of Convertible Senior Notes (Business Wire) -6.44%
09:50AM	AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway (PR Newswire)
07:00AM	Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense (Business Wire)
02:42AM	Tempus AI's Ambry Genetics Leads with Validated 99.5% Accurate Hereditary Cancer Risk Assessment Tool (Insider Monkey)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-27-25 09:15AM	Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last? (Zacks)
Jun-25-25 05:00PM	Ambry Genetics CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing (Business Wire)
10:15AM	Agentic AI Market worth $140.80 billion by 2032- Exclusive Report by MarketsandMarkets (PR Newswire)
Jun-24-25 07:25PM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey)
Jun-23-25 03:00PM	TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now? (Zacks)
08:41AM	Loading…
Jun-20-25 08:41AM	Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building? (Zacks)
Jun-19-25 09:01AM	Biovica International AB (FRA:9II) Q4 2025 Earnings Call Highlights: Strategic Partnerships and ... (GuruFocus.com)
Jun-17-25 09:33AM	Members of Congress Are Pouring Millions Into These 7 Surprising Stocks (Motley Fool)
08:30AM	Tempus to Participate in TD Cowen's 4th Annual Tools/Dx Revolution Conference (Business Wire)
Jun-13-25 12:07PM	Tempus AI's Expanding Ties Boost Novel R&D Efforts and Market Reach (Zacks)
Jun-12-25 03:47PM	Veteran analyst unveils bold price target for Tempus AI stock (TheStreet)
08:30AM	Tempus Announces Collaboration with Northwestern Universitys Abrams Research Center on Neurogenomics to Leverage AI for Alzheimers Disease Research (Business Wire)
Jun-09-25 03:00PM	Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today? (Zacks) +7.85%
Jun-06-25 01:55PM	Why Shares of Tempus AI Are Jumping Higher This Week (Motley Fool) +5.81%
09:09AM	Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape? (Zacks)
04:41AM	Zacks Investment Ideas feature highlights: Tempus AI, SoundHound AI and Innodata (Zacks)
Jun-05-25 11:30AM	3 AI Stocks Flying Under the Radar (Zacks) -6.56%
11:07AM	Update! What Is Congress Trading So Far In 2025? (MarketBeat)
05:00AM	Zacks Investment Ideas feature highlights: Nvidia, Alphabet, Constellation Energy and Meta Platform (Zacks)
Jun-04-25 09:45AM	Beyond LLMs: How Propense.ai & Tempus AI are Shaking up Legacy Industries (Zacks)
02:23AM	Loading…
Jun-03-25 02:23AM	Why Tempus AI, Inc. (TEM) Skyrocketed On Monday (Insider Monkey)
Jun-02-25 05:22PM	Why Tempus AI Stock Soared 15% Today (Motley Fool) +15.02%
04:17PM	Tempus AI recovers 15% as Wall Street downplays Spruce Point allegations (Investing.com)
02:13PM	Tempus AI rebound, Meta's AI ad push, Broadcom earnings optimism (Yahoo Finance Video)
08:30AM	Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers (Business Wire)
Jun-01-25 02:33PM	Cathie Wood buys $13.9 million of popular AI stock (TheStreet)
08:30AM	Introducing Tempus One in the EHR with Integrated Guidelines (Business Wire)
May-31-25 01:33PM	Tempus AI hits back at scathing short report (TheStreet)
08:40AM	Tempus AI announces 10 abstracts accepted for presentation at 2025 ASCO meeting (TipRanks)
08:30AM	Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model (Business Wire)
May-30-25 11:23AM	Tempus AI Stock: Buy the Dip, or Is the Short-Seller Right? (Motley Fool)
10:06AM	Why Tempus AI Stock Plummeted This Week (Motley Fool)
09:09AM	Real-World Deployments Signal AI Healthcare Is Ready for Scale (PR Newswire)
08:30AM	Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting (Business Wire)
May-29-25 05:45AM	Why Tempus AI, Inc. (TEM) Went Down On Wednesday (Insider Monkey)
May-28-25 03:57PM	Tempus AI, Box earnings, Victoria's Secret: Trending Tickers (Yahoo Finance Video) -19.23%
02:32PM	A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today (Motley Fool)
02:08PM	Nvidia earnings, Tempus AI short, Vail Resorts CEO returns (Yahoo Finance Video)
12:41PM	Why Artificial Intelligence Stock Tempus AI Is Tumbling Today (Motley Fool)
09:10AM	Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Tempus AI, Inc. (Nasdaq: TEM) (Business Wire)
08:30AM	A Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 Years (Business Wire)
May-27-25 06:15AM	New Study Shows Impact of Ambry Genetics Patient for Life Program on Rare Disease Diagnosis (Business Wire) +5.29%
May-26-25 03:00PM	Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy? (Zacks)
May-23-25 02:30AM	These Investors Search for Extreme Winners. Why Aurora, BYD, Tempus AI Make the Cut. (Barrons.com) +5.59%
May-21-25 12:57PM	Options Trading Now Available on Three Tradr ETFs: QBTX, TEMT and APPX (PR Newswire) -6.87%
08:48AM	Zacks Investment Ideas feature highlights: Palantir, Tempus AI and Comfort Systems USA (Zacks)
08:30AM	Tempus to Present at the William Blair 45th Annual Growth Stock Conference (Business Wire)
May-20-25 11:39AM	Tempus partners with Verastem for companion diagnostic development (Medical Device Network)
11:15AM	These 3 AI-Related Stocks Crushed Earnings (Zacks)
08:30AM	Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment (Business Wire)
07:33AM	From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room (PR Newswire)
May-19-25 11:16AM	Should You be Confident in Tempus AI (TEM)? (Insider Monkey)
May-15-25 03:00PM	After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? (Zacks)
04:48AM	Boehringer partners Tempus AI to enhance cancer therapy pipeline (Pharmaceutical Technology)
May-14-25 08:30AM	Tempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline (Business Wire) -5.99%
May-13-25 07:40PM	Why Tempus AI Inc. (TEM) Skyrocketed On Tuesday (Insider Monkey) +9.92%
04:05PM	Tempus Announces Six Posters Accepted for Presentation at ISPOR 2025 (Business Wire)
11:34AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (and Sold) (Motley Fool)
11:11AM	Is Tempus AI, Inc. (TEM) the Best Performing Healthcare Stock to Buy Now? (Insider Monkey)
06:45AM	Tradr Launches First Leveraged ETF on Tempus AI (PR Newswire)
May-10-25 09:50AM	Jim Cramer Says Stay Away from This Nancy Pelosi Stock (Insider Monkey)
07:00AM	MarketBeat Week in Review - 05/05 - 05/09 (MarketBeat)
May-09-25 11:30AM	These AI Stocks Posted Robust Results: Time to Buy? (Zacks) -5.90%
May-08-25 07:45AM	Tempus AI Stock: Time to Double Down or Cut and Run? (MarketBeat) +10.99%
01:48AM	Why Tempus AI, Inc. (TEM) Skyrocketed On Wednesday (Insider Monkey)
May-07-25 12:34PM	Q1 2025 Tempus AI Inc Earnings Call (Thomson Reuters StreetEvents) +12.59%
07:49AM	Tempus AI, Inc. (TEM): Among Most Popular Stocks on Robinhood in 2025 (Insider Monkey)
03:22AM	Tempus AI Inc (TEM) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
May-06-25 04:01PM	Tempus Reports First Quarter 2025 Results (Business Wire)
May-05-25 05:07PM	Jim Cramer Warns on Tempus AI (TEM): "Diagnostics With no Dough? I'm Out" (Insider Monkey) -5.24%
12:35PM	AI Healthcare Boom Gains Speed as Regulators and Innovators Align (PR Newswire)
08:30AM	Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry (Business Wire)
May-02-25 08:58AM	Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time. (Motley Fool) +10.05%
05:32AM	Tempus selects TIME Network for Phase I clinical trials (Clinical Trials Arena)
May-01-25 11:04AM	New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty (PR Newswire)
08:30AM	Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment (Business Wire)
Apr-30-25 05:32AM	Is This the Best Nancy Pelosi Stock to Buy After a 40% Pullback? (Motley Fool)
Apr-29-25 08:45AM	Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth (GlobeNewswire)
08:30AM	Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection (Business Wire)
Apr-28-25 03:00PM	Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings? (Zacks)
08:30AM	Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform (Business Wire)
Apr-26-25 02:04PM	Why Tempus AI Inc. (TEM) Soared Last Week (Insider Monkey)
Apr-25-25 08:30AM	Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 (Business Wire)
07:29AM	Tempus AI, AstraZeneca, and Pathos AI join forces on cancer care (Pharmaceutical Business Review)
04:49AM	The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS (Zacks)
Apr-24-25 03:00PM	Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal? (Zacks) +7.97%
08:30AM	Tempus to Report First Quarter 2025 Financial Results on May 6 (Business Wire)
07:33AM	AstraZeneca enters $200m AI cancer pact with Tempus and Pathos (Pharmaceutical Technology)
Apr-23-25 07:59PM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey) +14.62%
06:16PM	Why Tempus AI Inc. (TEM) Went Up On Wednesday (Insider Monkey)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Doudna Jennifer A	Director	Jul 01 '25	Sale	62.52	625	39,075	26,554	Jul 03 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 17 '25	Sale	70.07	250,000	17,516,593	9,357,283	Jun 20 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 18 '25	Sale	69.44	250,000	17,359,469	9,307,283	Jun 20 04:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Jun 16 '25	Sale	72.56	51,317	3,723,634	97,779	Jun 18 04:15 PM
Polovin Andrew	EVP and General Counsel	Jun 16 '25	Sale	72.13	1,423	102,641	137,454	Jun 18 04:15 PM
Eric Paul Lefkofsky	Officer	Jun 17 '25	Proposed Sale	72.00	400,000	28,800,000		Jun 17 09:45 PM
ERIK PHELPS	Officer	Jun 16 '25	Proposed Sale	71.28	51,317	3,657,876		Jun 16 04:30 PM
ANDREW POLOVIN	Officer	Jun 16 '25	Proposed Sale	71.28	1,423	101,431		Jun 16 04:22 PM
Leonsis Theodore	Director	Jun 11 '25	Sale	67.66	205,847	13,927,976	0	Jun 13 04:15 PM
Revolution Growth Management C	Shareholder	Jun 11 '25	Proposed Sale	69.38	205,847	14,281,665		Jun 11 04:02 PM
Fukushima Ryan	Chief Operating Officer	Jun 03 '25	Sale	62.29	20,000	1,245,764	856,640	Jun 05 04:15 PM
Doudna Jennifer A	Director	Jun 02 '25	Sale	55.20	558	30,802	27,179	Jun 04 04:15 PM
Epstein David R	Director	Jun 02 '25	Sale	55.20	250	13,800	27,661	Jun 04 04:15 PM
JENNIFER A DOUDNA	Director	Jun 02 '25	Proposed Sale	55.18	1,183	65,278		Jun 02 04:32 PM
Rogers James William	Chief Financial Officer	May 20 '25	Sale	63.27	23,121	1,462,809	146,001	May 22 08:00 PM
Polovin Andrew	EVP and General Counsel	May 20 '25	Sale	63.43	17,552	1,113,385	138,877	May 22 08:00 PM
Phelps Erik	EVP & Chief Admin & Legal Off	May 20 '25	Sale	63.21	8,415	531,918	149,096	May 22 08:00 PM
LEFKOFSKY ERIC P	CEO and Chairman	May 20 '25	Sale	63.21	16,752	1,058,905	4,878,837	May 22 08:00 PM
Fukushima Ryan	Chief Operating Officer	May 20 '25	Sale	63.21	7,820	494,308	876,640	May 22 08:00 PM
Bartolucci Ryan M	Chief Accounting Officer	May 20 '25	Sale	63.23	6,073	384,023	47,799	May 22 08:00 PM
Ryan M. Bartolucci	Officer	May 20 '25	Proposed Sale	63.74	4,254	271,150		May 21 07:39 PM
Ryan Fukushima	Officer	May 20 '25	Proposed Sale	63.74	7,820	498,447		May 21 07:36 PM
Andrew Polovin	Officer	May 20 '25	Proposed Sale	63.74	9,797	624,461		May 21 07:25 PM
Eric Paul Lefkofsky	Officer	May 20 '25	Proposed Sale	63.74	16,752	1,067,772		May 21 07:23 PM
Erik Phelps	Officer	May 20 '25	Proposed Sale	63.74	8,415	536,372		May 21 07:20 PM
James William Rogers	Officer	May 20 '25	Proposed Sale	63.74	11,413	727,465		May 21 07:18 PM
RYAN BARTOLUCCI	Officer	May 20 '25	Proposed Sale	63.74	1,819	115,943		May 20 04:32 PM
ANDREW POLOVIN	Officer	May 20 '25	Proposed Sale	63.74	7,755	494,304		May 20 04:31 PM
JAMES ROGERS	Officer	May 20 '25	Proposed Sale	63.74	11,708	746,268		May 20 04:31 PM
Leonsis Theodore	Director	May 09 '25	Sale	66.26	770	51,020	43,550	May 13 04:15 PM
REVOLUTION GROWTH III, LP	Shareholder	May 09 '25	Proposed Sale	65.22	770	50,219		May 09 04:18 PM
Fukushima Ryan	Chief Operating Officer	May 06 '25	Sale	52.36	20,000	1,047,239	884,460	May 08 04:30 PM
Epstein David R	Director	May 01 '25	Sale	53.50	370	19,795	25,914	May 05 04:15 PM
Gottlieb Scott	Director	Apr 01 '25	Sale	47.21	27,837	1,314,154	32,839	Apr 03 05:30 PM
Doudna Jennifer A	Director	Apr 01 '25	Sale	48.12	625	30,075	25,740	Apr 03 04:15 PM
Fukushima Ryan	Chief Operating Officer	Apr 01 '25	Sale	47.20	20,000	944,085	904,460	Apr 03 04:15 PM
Frederick Wayne A.I.	Director	Mar 31 '25	Sale	45.54	3,000	136,620	26,514	Apr 02 06:13 PM
RYAN FUKUSHIMA	Officer	Apr 01 '25	Proposed Sale	48.24	60,000	2,894,400		Apr 01 04:22 PM
Polovin Andrew	EVP and General Counsel	Mar 21 '25	Sale	50.00	3,076	153,800	151,095	Mar 25 04:15 PM
ANDREW POLOVIN	Officer	Mar 21 '25	Proposed Sale	48.04	3,076	147,771		Mar 21 04:21 PM
Rogers James William	Chief Financial Officer	Mar 18 '25	Sale	45.97	23,030	1,058,699	164,750	Mar 19 06:30 PM
Polovin Andrew	EVP and General Counsel	Mar 18 '25	Sale	45.98	13,135	603,970	154,171	Mar 19 06:30 PM
Epstein David R	Director	Mar 17 '25	Sale	46.83	990	46,362	26,284	Mar 19 06:30 PM
West Nadja	Director	Mar 17 '25	Sale	48.86	7,634	372,962	30,071	Mar 19 06:30 PM
Gottlieb Scott	Director	Mar 17 '25	Sale	48.85	27,838	1,359,989	60,676	Mar 19 06:30 PM
Frederick Wayne A.I.	Director	Mar 17 '25	Sale	48.85	9,000	439,659	29,514	Mar 19 06:30 PM
Doudna Jennifer A	Director	Mar 17 '25	Sale	48.80	9,308	454,210	26,365	Mar 19 06:30 PM
ANDREW POLOVIN	Officer	Mar 18 '25	Proposed Sale	49.87	13,135	655,042		Mar 18 04:41 PM
JAMES ROGERS	Officer	Mar 18 '25	Proposed Sale	49.87	23,030	1,148,506		Mar 18 04:27 PM
WAYNE FREDERICK	Director	Mar 17 '25	Proposed Sale	47.17	12,000	566,040		Mar 17 04:47 PM
DAVID R. EPSTEIN	Director	Mar 17 '25	Proposed Sale	47.17	1,610	75,944		Mar 17 04:25 PM
SCOTT GOTTLIEB	Director	Mar 17 '25	Proposed Sale	47.17	55,675	2,626,190		Mar 17 04:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 05 '25	Sale	50.93	562,345	28,641,725	9,457,283	Mar 07 04:56 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 06 '25	Sale	49.83	250,000	12,457,454	9,407,283	Mar 07 04:56 PM
Fukushima Ryan	Chief Operating Officer	Mar 04 '25	Sale	51.15	20,000	1,022,974	924,460	Mar 06 05:05 PM
West Nadja	Director	Mar 04 '25	Sale	51.11	809	41,347	37,705	Mar 06 05:05 PM
Eric P. Lefkofsky	Officer	Mar 05 '25	Proposed Sale	52.73	662,345	34,925,452		Mar 05 05:44 PM
Doudna Jennifer A	Director	Mar 03 '25	Sale	57.52	338	19,442	35,673	Mar 05 04:15 PM
Epstein David R	Director	Mar 03 '25	Sale	57.52	250	14,380	27,274	Mar 05 04:15 PM
NADJA WEST	Director	Mar 04 '25	Proposed Sale	50.93	8,443	430,002		Mar 04 05:08 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 27 '25	Sale	58.75	3,240,234	190,363,748	0	Feb 27 07:39 PM
Lightbank Investments 1B, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	115,751	6,840,884		Feb 27 04:27 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,580,928	93,432,845		Feb 27 04:26 PM
Lightbank Global, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,397,589	82,597,510		Feb 27 04:25 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	145,966	8,626,591		Feb 27 04:24 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '25	Sale	80.87	84,640	6,844,680	4,964,820	Feb 20 07:55 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 20 '25	Sale	74.09	69,231	5,129,325	4,895,589	Feb 20 07:55 PM
Fukushima Ryan	Chief Operating Officer	Feb 19 '25	Sale	81.87	2,868	234,814	944,460	Feb 20 07:55 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 20 '25	Sale	80.00	1,682	134,560	44,500	Feb 20 07:55 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 19 '25	Sale	81.87	818	66,973	46,182	Feb 20 07:55 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 18 '25	Sale	82.36	61,582	5,072,077	153,080	Feb 20 07:55 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 19 '25	Sale	81.87	903	73,932	152,177	Feb 20 07:55 PM
Polovin Andrew	EVP and General Counsel	Feb 18 '25	Sale	82.32	64,381	5,299,820	172,857	Feb 20 07:55 PM
Polovin Andrew	EVP and General Counsel	Feb 19 '25	Sale	81.87	5,551	454,470	167,306	Feb 20 07:55 PM
Rogers James William	Chief Financial Officer	Feb 18 '25	Sale	82.33	31,780	2,616,308	189,320	Feb 20 07:55 PM
Rogers James William	Chief Financial Officer	Feb 19 '25	Sale	81.87	1,540	126,086	187,780	Feb 20 07:55 PM
RYAN BARTOLUCCI	Officer	Feb 20 '25	Proposed Sale	85.71	1,682	144,164		Feb 20 04:22 PM
JAMES ROGERS	Officer	Feb 18 '25	Proposed Sale	89.44	31,780	2,842,403		Feb 18 04:29 PM
ANDREW POLOVIN	Officer	Feb 18 '25	Proposed Sale	89.44	64,381	5,758,237		Feb 18 04:29 PM
ERIK PHELPS	Officer	Feb 18 '25	Proposed Sale	89.44	61,582	5,507,894		Feb 18 04:28 PM
Doudna Jennifer A	Director	Feb 14 '25	Sale	90.00	1,320	118,800	36,011	Feb 14 07:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 14 '25	Sale	85.78	80,003	6,862,467	5,049,460	Feb 14 04:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 13 '25	Sale	78.51	78,594	6,170,792	5,129,463	Feb 14 04:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 12 '25	Sale	70.02	84,948	5,948,059	5,208,057	Feb 14 04:33 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 13 '25	Sale	80.00	6,059	484,720	47,000	Feb 14 04:32 PM
JENNIFER A DOUDNA	Director	Feb 14 '25	Proposed Sale	83.75	11,253	942,439		Feb 14 04:23 PM
RYAN BARTOLUCCI	Officer	Feb 13 '25	Proposed Sale	73.88	6,059	447,639		Feb 13 04:31 PM
LEFKOFSKY ERIC P	Officer	Feb 12 '25	Proposed Sale	71.21	535,000	38,097,350		Feb 12 08:21 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 05 '25	Sale	67.57	5,934	400,960	214,662	Feb 07 05:38 PM
Polovin Andrew	EVP and General Counsel	Feb 05 '25	Sale	67.57	7,717	521,438	237,238	Feb 07 05:36 PM
Rogers James William	Chief Financial Officer	Feb 05 '25	Sale	67.57	8,712	588,670	221,100	Feb 07 05:35 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 06 '25	Sale	71.00	2,320	164,720	53,059	Feb 07 05:34 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 05 '25	Sale	67.57	1,858	125,545	55,379	Feb 07 05:34 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 06 '25	Sale	67.89	85,109	5,778,114	5,373,393	Feb 07 05:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 07 '25	Sale	67.53	80,388	5,428,398	5,293,005	Feb 07 05:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 05 '25	Sale	67.53	74,485	5,030,067	5,458,502	Feb 07 05:33 PM
Fukushima Ryan	Chief Operating Officer	Feb 04 '25	Sale	62.50	20,000	1,250,033	962,442	Feb 06 06:02 PM
Fukushima Ryan	Chief Operating Officer	Feb 05 '25	Sale	67.57	15,114	1,021,253	947,328	Feb 06 06:02 PM
RYAN BARTOLUCCI	Officer	Feb 06 '25	Proposed Sale	69.18	2,320	160,498		Feb 06 04:23 PM
Epstein David R	Director	Feb 03 '25	Sale	53.31	370	19,725	27,524	Feb 05 06:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TEM

Tempus AI Inc

Upgrade your FINVIZ experience